These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 18172605)
21. PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells. Hong G; Lockhart A; Davis B; Rahmoune H; Baker S; Ye L; Thompson P; Shou Y; O'Shaughnessy K; Ronco P; Brown J FASEB J; 2003 Oct; 17(13):1966-8. PubMed ID: 12923071 [TBL] [Abstract][Full Text] [Related]
22. Intracellular calcium plays a role as the second messenger of hypotonic stress in gene regulation of SGK1 and ENaC in renal epithelial A6 cells. Taruno A; Niisato N; Marunaka Y Am J Physiol Renal Physiol; 2008 Jan; 294(1):F177-86. PubMed ID: 17959754 [TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney. Borsting E; Cheng VP; Glass CK; Vallon V; Cunard R Am J Physiol Renal Physiol; 2012 Mar; 302(5):F540-51. PubMed ID: 22169011 [TBL] [Abstract][Full Text] [Related]
24. Aldosterone-induced abnormal regulation of ENaC and SGK1 in Dahl salt-sensitive rat. Aoi W; Niisato N; Sawabe Y; Miyazaki H; Marunaka Y Biochem Biophys Res Commun; 2006 Mar; 341(2):376-81. PubMed ID: 16426574 [TBL] [Abstract][Full Text] [Related]
25. Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney. Wilson SM; Mansley MK; Getty J; Husband EM; Inglis SK; Hansen MK Br J Pharmacol; 2010 Feb; 159(3):678-88. PubMed ID: 20105179 [TBL] [Abstract][Full Text] [Related]
26. High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Hills CE; Bland R; Bennett J; Ronco PM; Squires PE Cell Physiol Biochem; 2006; 18(6):337-46. PubMed ID: 17170520 [TBL] [Abstract][Full Text] [Related]
27. PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules. Fu Y; Gerasimova M; Batz F; Kuczkowski A; Alam Y; Sanders PW; Ronzaud C; Hummler E; Vallon V Nephron; 2015; 129(1):68-74. PubMed ID: 25531136 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Lang F; Voelkl J Expert Opin Investig Drugs; 2013 Jun; 22(6):701-14. PubMed ID: 23506284 [TBL] [Abstract][Full Text] [Related]
29. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Lang F; Böhmer C; Palmada M; Seebohm G; Strutz-Seebohm N; Vallon V Physiol Rev; 2006 Oct; 86(4):1151-78. PubMed ID: 17015487 [TBL] [Abstract][Full Text] [Related]
30. Gene regulation of ENaC subunits by serum- and glucocorticoid-inducible kinase-1. Boyd C; Náray-Fejes-Tóth A Am J Physiol Renal Physiol; 2005 Mar; 288(3):F505-12. PubMed ID: 15536167 [TBL] [Abstract][Full Text] [Related]
31. Significance of SGK1 in the regulation of neuronal function. Lang F; Strutz-Seebohm N; Seebohm G; Lang UE J Physiol; 2010 Sep; 588(Pt 18):3349-54. PubMed ID: 20530112 [TBL] [Abstract][Full Text] [Related]
32. Epithelial Na⁺ channel activity in human airway epithelial cells: the role of serum and glucocorticoid-inducible kinase 1. Watt GB; Ismail NA; Caballero AG; Land SC; Wilson SM Br J Pharmacol; 2012 Jun; 166(4):1272-89. PubMed ID: 22250980 [TBL] [Abstract][Full Text] [Related]
33. SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. Vallon V; Wyatt AW; Klingel K; Huang DY; Hussain A; Berchtold S; Friedrich B; Grahammer F; Belaiba RS; Görlach A; Wulff P; Daut J; Dalton ND; Ross J; Flögel U; Schrader J; Osswald H; Kandolf R; Kuhl D; Lang F J Mol Med (Berl); 2006 May; 84(5):396-404. PubMed ID: 16604333 [TBL] [Abstract][Full Text] [Related]